加载中
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
前收盘价
US$4.37
−US$0.25 · -5.41%
盘后
US$4.37
US$0.00 · 0.00%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
日内区间
当前US$4.37
52周区间
当前US$4.37
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
31
偏贵
情绪
43
多空交织
风险
82
极高风险
动量
23
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
日内区间
当前US$4.37
52周区间
当前US$4.37
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3567.6万 USD | 5950.5万 USD | 7607.1万 USD | 3340.1万 USD | 898万 USD |
| 销货成本 | 4049.7万 USD | 4700.8万 USD | 5833.3万 USD | 2015万 USD | 655.5万 USD |
| 毛利 | −482.1万 USD | 1249.7万 USD | 1773.8万 USD | 1325.1万 USD | 242.5万 USD |
| 研究与开发 | 23.8万 USD | 41.8万 USD | 6.2万 USD | 38.8万 USD | 13.2万 USD |
| 销售、一般及管理费用 | 120.8万 USD | 2307.8万 USD | 2333.5万 USD | 2877.7万 USD | 1775.6万 USD |
| 营业费用 | 474.1万 USD | 2814.2万 USD | 6809.2万 USD | 6047.2万 USD | 2142.8万 USD |
| 利息收入 | — | — | — | 2.9万 USD | — |
| 利息支出 | 19.9万 USD | 21.3万 USD | 9.2万 USD | — | 3.2万 USD |
| 折旧和摊销 | 58.2万 USD | 76.8万 USD | 233.5万 USD | 262.9万 USD | 50.1万 USD |
| 营业利润 | −956.2万 USD | −1564.5万 USD | −5035.4万 USD | −4722.1万 USD | −1900.3万 USD |
| 净利润 | −1.21亿 USD | −1590.7万 USD | −5703.6万 USD | −5241.5万 USD | −2124.9万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$185
上涨空间 4133.41%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2025年8月4日 | 1:39 | — | — |
股票拆分 | 2023年6月9日 | 1:20 | — | — |
已生效 2025年8月4日
1:39
已生效 2023年6月9日
1:20
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
